MATERIALISE NV (MTLS)
Euronext Brussels · Belgium · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 7.700 |
|---|---|
| 52-week range | 4.300 – 8.000 |
| Return, 1 month / 3 months | +6.9% / +35.1% |
| Return, 1 year / 3 years | – / – |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 42.8% |
| Worst drawdown (1 year) | -17.8% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Materialise is a Belgian company based in Leuven that works in additive manufacturing, also called three-dimensional printing. It develops software that helps designers and engineers prepare digital models for printing, and it supplies printing services and consulting to industrial customers in sectors such as healthcare, automotive and consumer products. Its medical division makes software for processing medical images and produces patient-specific implants and surgical guides used by hospitals and clinicians.
On this site MATERIALISE NV appears as a stock on the Euronext Brussels (Belgium), code MTLS, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MATERIALISE NV (MTLS) trades on the Euronext Brussels in Belgium. It last closed at EUR 7.700 on 27 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 14 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 97 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 37.4% | ||
| From 52-week high | -1.9% | ||
| Momentum | 100 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 35.1% | ||
| 6-month return | 67.4% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.8% | ||
| Liquidity | 36 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +8.5% |
|---|---|
| 1 month | +6.9% |
| 3 months | +35.1% |
| 6 months | +67.4% |
| 1 year | – |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 6.851 / 5.603 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.372 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.